StockScope
← back to screener

UNH

UnitedHealth Group
US· Healthcare$480.00📅 Earnings in 25d
Signal
Hold
Est. 12-month return
+0.1%
Confidence
34%
Model ensemble · 6 algorithms voting
ModelStyleSignalEst. 12mConf.Why
Multi-FactorFactor investing (AQR)Hold-2.0%60%Composite factor score 43/100 vs market average of 50.
Analyst ConsensusSell-side researchBuy+10.0%50%Consensus target implies 17% upside (haircut for optimism).
Time-Series MomentumTrend funds (Man AHL)Avoid-7.4%25%12-month trend -20%, at 70% of 52w high.
Trend-Following (MA cross)CTA / managed futuresAvoid-7.9%45%Below trend: price -14% vs 200-day average.
Mean Reversion (RSI/Bollinger)Technical / contrarianHold+3.4%40%RSI 32, -0.7σ from mean — oversold, bounce likely.
Low-VolatilityRisk-premia (min-vol)Hold+1.0%40%Annualized volatility 25% — calmer than average.

Six independent models each vote with an expected return and confidence; the headline figure is their confidence-weighted blend (how quant funds combine uncorrelated signals). It is a modelled estimate, not a promise — markets are partly unpredictable, so treat a strong signal as a reason to research, never as a certainty.

Insider activity (SEC Form 4)
Heavy Buying
5 insider buys · 1 sell · net +$12.0M (trailing 90d).
Options flow · Options flow is a paid feed and is not configured. Set OPTIONS_FLOW_VENDOR (polygon | unusualwhales | tradier | cboe) and OPTIONS_FLOW_API_KEY, then run the options ingest.

Recent news

Headline sentiment:bearish(-0.79 · 3 headlines)
UnitedHealth Group slips as growth concerns weigh on shares
Sample Newswire · 6/3/2026
UNH downgraded amid weak demand and margin warning
Sample Newswire · 6/2/2026
UnitedHealth Group misses revenue view, cuts full-year outlook
Sample Newswire · 6/1/2026

Sentiment is a transparent finance-word lexicon score on the headline text only — a soft signal, not a recommendation.

Quant grades

graded vs 18 US peers · letter = percentile rank
Overall
D-
43
Value
B+
60
Quality
D+
42
Momentum
D-
22
Growth
B
50

Valuation

Trailing P/E16.00
Forward P/E13.00
Price / Book4.00
Price / Sales1.00
EV / EBITDA10.00
Dividend Yield1.8%

Quality & Growth

Return on Equity24.0%
Profit Margin6.0%
Debt / Equity70.00
Earnings Growth (yoy)8.0%
Revenue Growth (yoy)9.0%

Momentum

3-month return-9.0%
6-month return-15.0%
12-month return-20.0%
Price vs 52w high70.0%

Analyst

Mean target$560.00
Implied upside16.7%
Consensusbuy

Dividend scorecard

Yield
1.8%C+
vs market dividend payers
Safety
C
Based on D/E 70% · margin 6%. Growth/consistency need dividend history (not in this dataset).

Peer comparison

US market · top by composite
StockPriceP/EValueQualityMoment.GrowthScore12m est.Signal
NVDA$180.0055.01177759760+8.4%Buy
META$620.0024.04761676258+6.6%Buy
GOOGL$200.0026.04758615855+5.2%Buy
JPM$280.0014.05953564755+4.0%Hold
BAC$46.0012.06249534654+3.9%Hold
XOM$115.0014.06447514152+2.7%Hold
CVX$160.0014.06547494252+2.6%Hold
MSFT$480.0036.03760555451+3.6%Hold

Factor scores rank this stock against others in the same market. A high score means it screens well on that dimension today — it is a starting point for research, not a signal to buy. Always confirm the fundamentals and understand the business before investing.